WASHINGTON Senator Debbie (D-MI), coordinator of the Senate's Health Care Task Force, who has worked for two years to bring the prescription drug issue to the forefront of national debate, commented today on House passage of a bill allowing reimportation of drugs from Canada:
"I am pleased that, in the face of strong pressure from the pharmaceutical industry, the issue of prescription drug reimportation came to the floor of the U.S. House and received strong bipartisan support.
"I believe the House vote, combined with earlier Senate passage of legislation that would allow for the safe reimportation of prescription drugs from Canada, sends a clear signal to House-Senate conferees that this provision should be a part of the final prescription drug benefit legislation that is now in conference.
"As a Michigan resident, I have long been aware of the vast price difference between the cost of drugs sold in the U.S. and the same drugs sold in Canada, and I have long been aware of the impact of the higher U.S. prices on senior citizens on fixed incomes, working Americans without health insurance, and businesses struggling to pay higher and higher health care premiums.
"The action of the U.S. House gives me greater confidence that we can move forward to ease the financial burden on millions of Americans and to lower prescription drug prices for everyone."